Net Income (Annual) Chart

View Net Income (Annual) for RCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2025 -48.59M
December 31, 2024 -61.84M
December 31, 2023 -35.38M
December 31, 2022 -26.66M
June 30, 2021 -26.58M
June 30, 2020 -42.03M
June 30, 2019 -25.14M
June 30, 2018 -12.80M
June 30, 2017 -8.681M
June 30, 2016 -7.475M
June 30, 2015 -5.920M
June 30, 2014 -4.725M
June 30, 2013 -8.303M
June 30, 2012 -7.910M
Date Value
June 30, 2011 -1.772M
June 30, 2010 -5.184M
June 30, 2009 -3.772M
June 30, 2008 -10.90M
June 30, 2007 -11.82M
June 30, 2006 -8.948M
June 30, 2005 -7.118M
June 30, 2004 -5.067M
June 30, 2003 -2.308M
December 31, 2002 -1.460M
December 31, 2001 -1.307M
December 31, 2000 -1.699M
December 31, 1999 -0.8012M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. 316.89M
Iovance Biotherapeutics, Inc. -390.98M
Amgen, Inc. 7.711B
Editas Medicine, Inc. -160.06M
Arcus Biosciences, Inc. -353.00M